N/A
Completed N=40
Telemedicine Strategy With Home Treatment Save Resources
Source: ClinicalTrials.gov NCT02214017 ↗Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Nov 2018
Primary outcomePrimary: Glycemia — 7.1; 7.6 percent of glycosylated hemoglobin
Summary
Progress in technology has made telemedicine-based solutions with video consultations available in the management and treatment of chronic diseases like diabetes, heart failure and lung insufficiency at home. However, no direct comparisons on health outcomes of telemedicine using video consultations versus usual outpatient treatment are available.
We wanted to implement a model of telemedicine and to evaluate health indicators in type 2 diabetes patients treated by video consultations or the standard outpatient treatment
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glycemia |
7.1; 7.6 | — |
| SECONDARY Lipids |
3.9; 3.6 | — |
Eligibility Criteria
Inclusion Criteria
The participants had to live at home, be able to communicate by videotelephone, had no psychiatric disorders, an age between 40 and 85 years and be able to administer medication. -
Exclusion Criteria
Exclusion criteria were type 1 diabetes, speech disabilities, non-Danish speakers or with severe chronic disease like renal failure (GFR<30 ml/min), liver insufficiency or in cancer treatment.
-
Data sourced from ClinicalTrials.gov (NCT02214017). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.